Results 341 to 350 of about 183,641 (351)

Polar Residues in the Transmembrane Domains of the Type 1 Angiotensin II Receptor Are Required for Binding and Coupling

Journal of Biological Chemistry, 1996
C. Monnot, C. Bihoreau, S. Conchon, K. M. Curnow, P. Corvol, E. Clauser   +5 more
semanticscholar   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists

Pharmacological Reviews, 2013
M. C. Michel, C. Foster, H. Brunner, Li-sheng Liu   +3 more
semanticscholar   +1 more source

Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Elizabeth A Mittendorf, Hope S Rugo, Gabriel N Hortobagyi   +2 more
exaly  

Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor.

HYPERTENSION, 1994
H. Kai, K. Griendling, B. Lassègue, J. Ollerenshaw, M. Runge, R. Alexander   +5 more
semanticscholar   +1 more source

Gastroenteropancreatic Neuroendocrine Tumors

Ca-A Cancer Journal for Clinicians, 2018
Mauro Cives
exaly  

Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies

Ca-A Cancer Journal for Clinicians, 2018
David A Mahvi, Rong Liu, Yolonda L Colson   +2 more
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Cancer of the esophagus and esophagogastric junction—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Deepa T Patil, David P Kelsen
exaly  

Breast cancer statistics, 2013

Ca-A Cancer Journal for Clinicians, 2014
exaly